BD has introduced the ability to execute in vitro rapid identification (ID) and antimicrobial susceptibility testing (AST) for meropenem-vaborbactam in its latest panel for the BD Phoenix Automated Microbiology System, which detects resistance in Enterobacteriaceae, Non-Enterobacteriaceae and most gram-positive bacteria isolates from pure culture belonging to the genera Staphylococcus, Enterococcus and Streptococcus.
The BD Phoenix offers clinical microbiology laboratories the ability to rapidly test antimicrobial resistances or susceptibilities. The company’s rapid results for ID and AST are powered through an oxidation-reduction indicator with turbidity measurement for growth detection, as well as full on-panel antimicrobial concentrations and the BDXpert system for data analysis.
Phone: 02 8875 7000
Fluidic Analytics Fluidity One-W for protein analysis
The Fluidity One-W instrument, from Fluidic Analytics, is able to assess on-target protein...
Integrated DNA Technologies oPools Oligo Pools
Integrated DNA Technologies (IDT) has launched oPools Oligo Pools — ready-to-use pools of...
Phase Genomics Hi-C proximity ligation kits
Phase Genomics applies Hi-C and other proximity-ligation methods to enable chromosome-scale...
